Drug Trial Radar · NCT05397600
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
Last checked: Nov 19, 2026Latest source record: Jul 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
684
Actual
Start
Jun 22, 2022
Primary completion
Mar 7, 2024
Study completion Mar 7, 2024
Sponsor
- Lead sponsor
- Laboratoires TheaIndustry
- Sponsor type
- Industry
- First posted
- May 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main study purpose is to demonstrate the non-inferiority of T4032 compared to Lumigan® 0.01% in terms of efficacy.
Conditions
- Glaucoma
- Ocular Hypertension
Interventions
Bimatoprost OphthalmicDrug
Eyedrops
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline (Day 1) to Week 2, Week 6, and Week 12 in IOP.Time frame: up to Week12
Locations
64 sites in 3 countries. Site status is shown where the registry gives one.
Arizona Eye Center - Chandler
Chandler, Arizona
Eye Physicians & Surgeons of Arizona - Glendale Office
Glendale, Arizona
Arizona Glaucoma Specialists - Phoenix
Phoenix, Arizona
Walman Eye Center - Sun City
Sun City, Arizona
Velvet Clinical Research
Burbank, California
Specialty Eye Care Medical Center - Glendale
Glendale, California
Global Research Management, Inc.
Glendale, California
Inland Eye Specialists - Hemet
Hemet, California
Diabetic Eye Medical Clinic - Inglewood
Inglewood, California
Lakeside Vision Center - Irvine
Irvine, California
Sage Eyecare
Los Angeles, California
Global Vision Eye Care - Los Angeles- Rock Central
Los Angeles, California
North Valley Eye Medical Group, Inc.
Mission Hills, California
California Eye Specialists Medical Group Inc. - Monrovia
Monrovia, California
Aesthetic Eye Care Institute - Eye Research Foundation
Newport Beach, California
Foothill Eye Institute - Pasadena
Pasadena, California
North Bay Eye Associates - Petaluma - 104 Lynch Creek Way
Petaluma, California
California Eye Specialists Medical Group Inc. - Redlands
Redlands, California
OC Surgical Eye Institute
Santa Ana, California
Santa Barbara Eyecare - Santa Barbara
Santa Barbara, California
Wolstan & Goldberg Eye Associates
Torrance, California
ICON Eye Care - Grand Junction
Grand Junction, Colorado
Nature Coast Clinical Research - Crystal River
Crystal River, Florida
East Coast Institute for Research - Jacksonville
Jacksonville, Florida
Ocala Eye - 3130 Location
Ocala, Florida
Bascom Palmer Eye Institute - University of Miami Health System - Palm Beach Gardens
Palm Beach Gardens, Florida
East Florida Eye Institute
Stuart, Florida
Coastal Research Associates, LLC. - Atlanta
Roswell, Georgia
Coastal Research Associates, LLC. - Atlanta
Roswell, Georgia
Indiana University School of Medicine - Eugene and Marilyn Glick Eye Institute
Indianapolis, Indiana
Fraser Eye Care Center - Fraser
Fraser, Michigan
Great Lakes Eye Care - St. Joseph
Saint Joseph, Michigan
Huron Ophthalmology, P.C.
Ypsilanti, Michigan
Comprehensive Eye Care, Ltd.
Washington, Missouri
NV Eye Surgery - Henderson
Henderson, Nevada
Rochester Ophthalmological Group, PC - Brighton
Rochester, New York
"Clinic-LJ" Ltd
Winston-Salem, North Carolina
Cincinnati Eye Institute - Blue Ash
Cincinnati, Ohio
Abrams Eye Center, Inc.
Cleveland, Ohio
AMA Eye Research Institute
Marysville, Ohio
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.